InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ALUMIS INC.

ALMS Clue Score37
United States Fiscal year ends December CIK 0001847367
$7.16 +2.73% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $7.16 +58.06% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 28 Jun 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Operating income−158.2Net income−155.0EPS, diluted−72.08Fiscal year 2024Operating income−300.8Net income−294.2EPS, diluted−10.38Fiscal year 2025Revenue24.1Operating income−453.8Net income−243.3EPS, diluted−2.86
FY2023FY2024FY2025
Revenue n/a n/a 24.1
Growth
Operating income −158.2 −300.8 −453.8
Net income −155.0 −294.2 −243.3
Growth
EPS, diluted −72.08 −10.38 −2.86

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2023Fiscal year 2024Fiscal year 2025Operating margin−1,886.9%Net margin−1,011.7%Free cash flow margin−1,539.2%
FY2023FY2024FY2025
Operating margin n/a n/a −1,886.9%
Net margin n/a n/a −1,011.7%
Free cash flow margin n/a n/a −1,539.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−130.0Capital expenditure−4.5Free cash flow−134.5Buybacks−0.1Fiscal year 2024Operating cash flow−255.1Capital expenditure−1.7Free cash flow−256.8Buybacks−0.0Fiscal year 2025Operating cash flow−369.5Capital expenditure−0.7Free cash flow−370.2Buybacks−0.0
FY2023FY2024FY2025
Operating cash flow −130.0 −255.1 −369.5
Capital expenditure −4.5 −1.7 −0.7
Free cash flow −134.5 −256.8 −370.2
Growth
Buybacks −0.1 −0.0 −0.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2023Cash46.0Shareholders’ equity−339.3Fiscal year 2024Cash169.5Shareholders’ equity260.1Fiscal year 2025Cash89.7Shareholders’ equity301.3
FY2023FY2024FY2025
Cash 46.0 169.5 89.7
Shareholders’ equity −339.3 260.1 301.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
46.0 169.5 89.7
22.4 21.0 18.2
89.6 341.0 411.9
Growth +280.5% +20.8%
Liabilities
53.5 80.9 110.6
Equity
−364.3 −658.6 −901.9
−339.3 260.1 301.3
Growth +15.8%